Impact of roflumilast on dyspnea and lung function in patients with chronic obstructive pulmonary disease: a pooled analysis of four clinical trials

被引：0
|
作者：
Rennard, Stephen I. [1 ]
Sun, Shawn X.
Tourkodimitris, Stavros
Rowe, Paul
Goehring, Udo M. [2 ]
Calverley, Peter M. A. [3 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Takeda Pharmaceut Int GmbH, Glattpark Opfikon, Switzerland
[3] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
QUALITY OF LIFE RESEARCH | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
3065
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Effect and safety of roflumilast for chronic obstructive pulmonary disease in Chinese patients
    Liu, Dong-yang
    Wang, Zhi-guo
    Gao, Yuan
    Zhang, Hui-min
    Zhang, Yu-xiang
    Wang, Xiao-jun
    Peng, Dan
    MEDICINE, 2018, 97 (07)
  • [32] Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease
    Ostrovskyy, Mykola
    Savelikhina, Iryna
    Ostrovska, Kseniia
    Varunkiv, Oleksandr
    Kulynych-Miskiv, Mariana
    Korzh, Galyna
    Shvets, Kostiantyn
    Korzh, Nadiia
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [33] Benefits of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease and interstitial lung disease with the same dyspnea severity
    Pedro, P. I.
    Santos, L. Maia
    Forte, C. Braco
    Dias, A.
    Cruz, C.
    Rodrigues, F.
    PULMONOLOGY, 2019, 25 (02): : 117 - 118
  • [34] A FACTOR-ANALYSIS OF DYSPNEA RATINGS, RESPIRATORY MUSCLE STRENGTH, AND LUNG-FUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    MAHLER, DA
    HARVER, A
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (02): : 467 - 470
  • [35] A FACTOR-ANALYSIS OF EXERCISE CAPACITY, DYSPNEA RATINGS, AND LUNG-FUNCTION IN PATIENTS WITH SEVERE CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    WEGNER, RE
    JORRES, R
    KIRSTEN, D
    MAGNUSSEN, H
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A743 - A743
  • [36] Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease
    Kim, Kyung Hoon
    Kang, Hye Seon
    Kim, Ju Sang
    Yoon, Hyoung Kyu
    Kim, Sung Kyoung
    Rhee, Chin Kook
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 3449 - 3456
  • [37] Impact of a Rehabilitation Program on Dyspnea Intensity and Quality in Patients with Chronic Obstructive Pulmonary Disease
    Bianchi, Roberto
    Gigliotti, Francesco
    Romagnoli, Isabella
    Lanini, Barbara
    Castellani, Carla
    Binazzi, Barbara
    Stendardi, Loredana
    Bruni, Giulia Innocenti
    Scano, Giorgio
    RESPIRATION, 2011, 81 (03) : 186 - 195
  • [38] Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease
    Stevenson, NJ
    Walker, PP
    Costello, RW
    Calverley, PMA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (12) : 1510 - 1516
  • [39] A POOLED SAFETY ANALYSIS OF ROFLUMILAST FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: TIME TO ONSET, DURATION AND SEVERITY OF ADVERSE EVENTS
    Wagner, B.
    Calverley, P. M. A.
    Fabbri, L. M.
    Rabe, K. F.
    Mosberg, H.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S177 - S178
  • [40] Postprandial dyspnea and malnutrition in patients with chronic obstructive pulmonary disease
    Gray-Donald, K
    Carrey, Z
    Martin, JG
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1998, 21 (03): : 135 - 141
12345